Therapure Biopharma is a contract development and manufacturing organisation (CDMO) that specialises in the development, scale-up and manufacture of complex biologics.
Therapure operates a modern 130,000ft2Â current good manufacturing practice (cGMP) facility in the Greater Toronto Area that is equipped with Class A to C cleanrooms, quality control (QC) and analytical labs, clinical and commercial-scale manufacturing suites, mammalian cell culture production capability with upstream and downstream processing, and aseptic fill/finish capacity.
With 28,000 ft2 of cGMP biomanufacturing space, including pilot, clinical and commercial scale production capacity Therapure is able to meet client’s scale-up needs. Therapure has more than 20 years of experience manufacturing a variety of sources of active pharmaceutical ingredients (API) covering mammalian cell culture, whole blood and plasma, and primary cell culture.
Upstream capabilities include Chinese Hamster Ovary (CHO), HEK-293, hybridoma and stem cell culture, master cell bank creation and media preparation. The company’s downstream expertise includes protein purification, protein modification and large-scale buffer preparation.
Therapure is a recognised global leader in their expertise in the production and purification of whole blood and plasma products.
Therapure is one of the only Canadian companies that offers aseptic fill/finish of glass vials, including Health Canada-licensed aseptic fill/finish suites.
A mutual recognition agreement (MRA) between Canada and the EU allows for selected aseptic fill/finished glass vials produced at Therapure to be sold directly into Europe without receiving country pre-inspections.
Lyophilisation development and optimisation services are available along with clinical and commercial scale lyophilisation capacity.
Therapure’s diverse group of clients continues to value the quality systems and a broad range of biomanufacturing and fill/finish services that Therapure provides.
The integrated service offering allows clients to remain with Therapure throughout the development and commercialization stages of production.
2585 Meadowpine Blvd.
Mississauga, ON
Canada L5N 8H9
Phone: 905-286-6200
Fax: 905-286-6300
busdev@therapurebio.com
www.therapurebio.com